Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shire
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Enrolled in LEVP2005-1 (current or in the past)
You may not be if
C1 inhibitor infusion within the last 7 days
Signs of any HAE attack
HAE attack within 7 days before actual infusion of C1INH-nf
Change in the dosage of androgens in the last 14 days before the study
Use of antifibrinolytics in the last 7 days before the study
Change in oral conceptive medication in the last two months before the study
History of clinically relevant antibody development to C1 inhibitor
Use of oral anticoagulant medication in the last 14 days
Use of heparin within the last two days prior to the study
History of allergic reaction to C1 inhibitor or other blood products
Current participation (or within the past 90 days) in any investigational drug study other than those sponsored by Lev Pharmaceuticals
Pregnancy or lactation
B-cell malignancy
Any clinically significant medical condition, such as renal failure, that in the opinion of the investigator would interfere with the subject's ability to participate in the study